InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 3 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding InMed Pharmaceuticals Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 9 | 20 | +11 |
| Shares | 319.3K | 2.70M | +2.38M (+744.8%) |
| Value | $206.0K | $4.18M | +$3.98M (+1,929.4%) |
New holders (13)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 800,000 | $1.24M | 0.06% |
| Vivo Capital, LLC | 798,377 | $1.24M | 0.11% |
| Squadron Capital Management LLC | 325,000 | $503.8K | 0.17% |
| Ikarian Capital, LLC | 245,025 | $379.8K | 0.06% |
| Ursa Fund Management, LLC | 125,800 | $195.0K | 0.03% |
| Suvretta Capital Management, LLC | 100,000 | $155.0K | 0.00% |
| Boothbay Fund Management, LLC | 74,244 | $115.1K | 0.00% |
| Jane Street Group, LLC | 43,078 | $66.8K | 0.00% |
| VR Adviser, LLC | 32,685 | $50.7K | 0.00% |
| Seven Grand Managers, LLC | 25,000 | $38.8K | 0.00% |
| Scientech Research LLC | 15,461 | $24.0K | 0.02% |
| Crestwood Advisors Group LLC | 14,900 | $23.1K | 0.00% |
| Stratos Wealth Partners, LTD. | 10,760 | $16.7K | 0.00% |
Sold out (2)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Virtu Financial LLC | 19,980 | $13.0K |
| UBS Group AG | 8,068 | $5.20K |